First New Progesterone Supplement in a Decade Debuts As a More Convenient
PARSIPPANY, N.J., Nov. 12 /PRNewswire/ -- According to a nationwide survey of 350 women conducted on the American Fertility Association (AFA) Web site, few women undergoing an Assisted Reproductive Technology (ART) treatment for infertility, such as in vitro fertilization (IVF), realize that as they approach the finish line comes another treatment -- progesterone supplementation. This extra boost of progesterone, which supports embryo implantation and early pregnancy, is extremely important for a successful pregnancy. The survey, Progesterone Therapy: The Patient Perspective, was supported by an educational grant from Ferring Pharmaceuticals.
"Progesterone supplementation is a rigorous process that women in ART treatments must undergo for up to 10 weeks to improve their chances of pregnancy," said Pamela Madsen, AFA Executive Director. "One clear and disturbing conclusion from the survey is that there should be far more dialog between patients and their doctor about this critical aspect of treatment and the various therapy choices."
Progesterone Therapy: The Patient Perspective
Surprisingly, many patients did not know about progesterone therapy and product options before they started treatment. For 44 percent, their doctor or nurse did not explain progesterone therapy. Nearly all (94 percent) said they had no input into the selection of a product. Typically, they use whatever the doctor recommends.
Most of the women surveyed (86 percent) were not completely satisfied with their progesterone treatment, and 80 percent feel there is a need for a more patient-friendly option. Nearly all said that if they knew there was a new product available that was just as effective as current therapies, but more comfortable and convenient, they would ask their doctor about it.
The majority (nearly two-thirds) used intramuscul
|SOURCE Ferring Pharmaceuticals|
Copyright©2007 PR Newswire.
All rights reserved